Catheter Historical Financial Ratios
VTAK Stock | 0.46 0.01 2.13% |
Catheter Precision is presently reporting on over 91 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 42.94, Dividend Yield of 0.0, PTB Ratio of 0.99 or Days Sales Outstanding of 72.74 will help investors to properly organize and evaluate Catheter Precision financial condition quickly.
Catheter |
About Catheter Financial Ratios Analysis
Catheter PrecisionFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Catheter Precision investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Catheter financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Catheter Precision history.
Catheter Precision Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Catheter Precision stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Catheter Precision sales, a figure that is much harder to manipulate than other Catheter Precision multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Catheter Precision's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Catheter Precision current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.At this time, Catheter Precision's Income Quality is quite stable compared to the past year. Debt To Equity is expected to rise to 0.03 this year, although Book Value Per Share will most likely fall to 4.21.
2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 1.75 | 0.0647 | 0.0744 | 0.0706 | Days Of Inventory On Hand | 118.81 | 535.33 | 481.8 | 505.89 |
Catheter Precision fundamentals Correlations
Click cells to compare fundamentals
Catheter Precision Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Catheter Precision fundamentals Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Price To Sales Ratio | 28.66 | 3.6K | 4.4K | 50.23 | 45.2 | 42.94 | |
Ptb Ratio | 5.97 | 5.76 | 6.58 | 1.05 | 0.94 | 0.99 | |
Days Sales Outstanding | 39.85 | 1.99 | 348.41 | 113.13 | 101.82 | 72.74 | |
Book Value Per Share | 622.34 | 135.38 | 8.96 | 3.86 | 4.44 | 4.21 | |
Free Cash Flow Yield | (0.22) | (0.35) | (0.37) | (0.93) | (1.07) | (1.02) | |
Operating Cash Flow Per Share | (832.96) | (273.51) | (21.83) | (3.75) | (3.38) | (3.55) | |
Stock Based Compensation To Revenue | 3.27 | 0.93 | 101.68 | 31.93 | 2.75 | 2.48 | |
Capex To Depreciation | 0.0283 | 0.17 | 0.0404 | 0.0366 | 0.0421 | 0.04 | |
Pb Ratio | 5.97 | 5.76 | 6.58 | 1.05 | 0.94 | 0.99 | |
Ev To Sales | 24.34 | 3.0K | 3.2K | 43.0 | 38.7 | 36.77 | |
Free Cash Flow Per Share | (834.93) | (276.14) | (21.84) | (3.77) | (3.39) | (3.56) | |
Roic | (1.35) | (1.84) | (2.87) | (2.74) | (3.15) | (3.31) | |
Inventory Turnover | 2.47 | 1.58 | 3.07 | 0.68 | 0.78 | 0.74 | |
Net Income Per Share | (1.1K) | (248.22) | (25.98) | (12.84) | (11.56) | (12.14) | |
Days Of Inventory On Hand | 147.68 | 230.7 | 118.81 | 535.33 | 481.8 | 505.89 | |
Payables Turnover | 11.64 | 1.58 | 1.75 | 0.0647 | 0.0744 | 0.0706 | |
Research And Ddevelopement To Revenue | 2.04 | 556.95 | 456.57 | 1.07 | 0.97 | 0.92 | |
Capex To Revenue | 0.0372 | 0.0152 | 12.05 | 1.21 | 0.17 | 0.15 | |
Cash Per Share | 703.53 | 148.96 | 15.34 | 0.65 | 0.75 | 0.71 | |
Pocfratio | (4.46) | (2.85) | (2.7) | (1.08) | (0.97) | (1.02) | |
Capex To Operating Cash Flow | (0.002367) | (0.009593) | (7.53E-4) | (0.003686) | (0.003317) | (0.003483) | |
Pfcf Ratio | (4.45) | (2.82) | (2.7) | (1.07) | (0.97) | (1.01) | |
Days Payables Outstanding | 31.36 | 231.17 | 208.57 | 5.6K | 5.1K | 5.3K | |
Income Quality | 0.79 | 1.1 | 0.84 | 0.29 | 0.26 | 0.5 | |
Roe | (1.7) | (1.83) | (2.9) | (3.33) | (3.83) | (3.64) | |
Ev To Operating Cash Flow | (3.79) | (2.39) | (2.0) | (0.92) | (0.83) | (0.87) | |
Pe Ratio | (3.5) | (3.14) | (2.27) | (0.31) | (0.28) | (0.3) | |
Return On Tangible Assets | (1.08) | (1.19) | (1.6) | (15.97) | (18.37) | (17.45) | |
Ev To Free Cash Flow | (3.78) | (2.37) | (2.0) | (0.92) | (0.83) | (0.87) | |
Earnings Yield | (0.29) | (0.32) | (0.44) | (3.18) | (3.66) | (3.47) | |
Net Debt To E B I T D A | 0.57 | 0.46 | 0.7 | 0.21 | 0.24 | 0.23 | |
Current Ratio | 3.56 | 3.17 | 2.22 | 1.68 | 1.94 | 1.84 | |
Tangible Book Value Per Share | 622.34 | 135.38 | 8.96 | (0.93) | (1.07) | (1.02) | |
Receivables Turnover | 9.16 | 183.54 | 1.05 | 3.23 | 2.9 | 2.76 | |
Graham Number | 3.9K | 869.52 | 72.36 | 33.38 | 38.39 | 36.47 | |
Shareholders Equity Per Share | 622.34 | 135.38 | 8.96 | 3.86 | 4.44 | 4.21 | |
Debt To Equity | 0.23 | 0.17 | 0.0134 | 0.0176 | 0.0158 | 0.0256 | |
Capex Per Share | 1.97 | 2.62 | 0.0164 | 0.0138 | 0.0159 | 0.0151 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Catheter Precision. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 30.61 | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.